Details for Cynarin
Cynarin
111Category: Pharmaceuticals and Biochemicals/Herbal Plant Extract
CAS NO: 1182-34-9 EC NO: 214-655-7 Molecular Formula: C25H24O12 Molecular Weight: 516.4509 Specification: Cynarin 0.5%, 2.5% ,5%Test By HPLC InChI: InChI=1/C25H24O12/c26-15-5-1-13(11-17(15)28)3-7-20(30)36-19-9-10-25(24(34)35,23(33)22(19)32)37-21(31)8-4-14-2-6-16(27)18(29)12-14/h1-8,11-12,19,22-23,26-29,32-33H,9-10H2,(H,34,35)/b7-3+,8-4+/t19-,22-,23+,25+/m1/s1 Packing: 25kg/fiber drum I.D.42CM x H52CM Product description:
-Name: Artichoke P.E. / Artichoke Leaf Extract / Artichoke Extract Powder
-Brand: HUAKANG
-Model: HK120092
-Category: Standard Herbal Extract
-Effectiveness: Liver protection
-Plant of Origin: Cynara scolymus L.
-Appearance: Brown Powder
-Specifications of Product
-Content Specifications: Cynarin 0.5%, 2.5% ,5%Test By HPLC
-Certificate:ISO9001,GMP
Function of Artichoke P.E. :
1.Increasing bile secretion and law constipation, diarrhea, nausea, and vomiting;
2.stimulating the secretion of bile law, preventing arteriosclerosis, and protect heart blood:
3.Playing an important role in relieving vascular purpura;
4.It can used for treatments of chronic hepatitis, reducing cholesterol and indigestion diseases, improving gastrointestinal function;
5.Anti Hepatic toxicity, choleretic agents, anti-high blood lipids (serum cholesterol);
6.With considerable effects on the malignant cells,ect.
Description
1.Artichoke has been used in traditional medicine for centuries as a specific liver and gallbladder remedy.
2.In Brazilian herbal medicine systems, leaf preparations are used for liver and gallbladder problems, diabetes, high cholesterol, hypertension, anemia, diarrhea (and elimination in general), fevers, ulcers, and gout.
3.In Europe, it is also used for liver and gallbladder disorders; in several countries, standardized herbal drugs are manufactured and sold as prescription drugs for high cholesterol and digestive and liver disordersRaw Material Picture:
Uses: pharmaceutical, health food Synonyms: (1R,3R,4S,5R)-1,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]oxy}-4,5-dihydroxycyclohexancarbons?ure;(1R,3R,4S,5R)-1,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid;(1R,3R,4S,5R)-1,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid;[1R-(1a,3a,4a,5b)]-1,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-4,5-dihydroxycyclohexanecarboxylic Acid;1,5-Dicaffeylquinic Acid;1-Carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate);3,4-Dihydroxycinnamic Acid 1-Carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester;Acide (1R,3R,4S,5R)-1,3-bis{[(2E)-3-(3,4-dihydroxyph¨¦nyl)-2-prop¨¨nan-1-oyl]oxy}-4,5-dihydroxycyclohexanecarboxylique;Caffeic Acid 1-Carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester;cyclohexanecarboxylic acid, 1,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-4,5-dihydroxy-, (1R,3R,4S,5R)-;1,4-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,5-dihydroxycyclohexanecarboxylic acid;4-{[3-(3,4-dihydroxyphenyl)acryloyl]oxy}-1-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,5-dihydroxycyclohexanecarboxylic acid;(3R,5R)-1-acetyl-3,5-dihydroxycyclohexane-1,4-diyl (2E,2'E)bis[3-(3,4-dihydroxyphenyl)prop-2-enoate];(1S,3R,4R,5R)-1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid;(1S,2S,3S,4R)-1,4-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,3-dihydroxycyclohexanecarboxylic acid;cynarin;Lynare Scolymusl P.E.;1,5-dicaffeoylquinic acid;cynarin(1,3-dicaffeoylquinic acid); Molecular Structure: 
Search Product